Agreement with $LLY - Rapidly Advancing NR2F6 Program Moving to Efficacy Phase in Trials for Cancers/Auto Immune Disorders-Creating Oral Drugs
Look at the Revolutionary Technology http://www.frontpagestocks.com/regen-biopharma-inc-rgbp/ #Biotechnology #FDA